1. The forgotten type 2 diabetes mellitus medicine: rosiglitazone
   Bo Xu et al, 2022, Diabetology International CrossRef
2. Icariin treatment reduces blood glucose levels in type�2 diabetic rats and protects pancreatic function
   Xin Li et al, 2020, Experimental and Therapeutic Medicine CrossRef
3. Development of an immunochromatographic strip for the detection of rosiglitazone in functional foods based on monoclonal antibodies
   Yuxi Chen et al, 2019, Analytical Methods CrossRef
4. Exploring the New Horizon of AdipoQ in Obesity-Related Alzheimer’s Dementia
   Md. Sahab Uddin et al, 2021, Frontiers in Physiology CrossRef
5. The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
   Leticia Forny-Germano et al, 2019, Frontiers in Neuroscience CrossRef
6. Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
   Priyamvada Amol Arte et al, 2023, Human Cell CrossRef
7. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China
   Siying Weng et al, 2018, Medicine CrossRef
8. Identification and screening of potential inhibitors obtained from Plumeria rubra L. compounds against type 2 diabetes mellitus
   Subhajit Hazra et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
9. The Association among Urinary Lead and Cadmium, Serum Adiponectin, and Serum Apoptotic Microparticles in a Young Taiwanese Population
   Chien-Yu Lin et al, 2023, Nutrients CrossRef
10. Plasma fatty acid metabolic profiling coupled with clinical research reveals the risk factors for atherosclerosis development in type 2 diabetes mellitus
    Qianyu Zhou et al, 2019, RSC Advances CrossRef